News & Press Featured Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025 BusinessWire • May 13, 2025 Read More All Sail Biomedicines to Present New Preclinical Data on Malaria eRNA™ Vaccine Candidates at the 2025 Grand Challenges Annual Meeting June 2, 2025 Q&A: Is the key to personalised medicine programmability? Pharmaceutical Manufacturer • May 30, 2025 Designing Our Way Toward Circular RNA Medicines With AI Advancing RNA • May 30, 2025 Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025 BusinessWire • May 13, 2025 Sail Biomedicines Appoints Laura Sepp-Lorenzino, Ph.D., to Its Board of Directors BusinessWire • April 7, 2025 Rajesh Ramaswamy: Teaching Machines to Generate Tomorrow's Medicines January 8, 2025 Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board Business Wire • April 2, 2024 Sail Biomedicines Appoints Kerry Benenato, Ph.D., as Chief Platform Officer Business Wire • February 7, 2024 Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines Business Wire • January 5, 2024 Load More
